List of Excipients in Branded Drug SUMATRIPTAN SUCCINATE

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Sandoz Inc	SUMATRIPTAN SUCCINATE	sumatriptan succinate	0781-3173	SODIUM CHLORIDE
Sandoz Inc	SUMATRIPTAN SUCCINATE	sumatriptan succinate	0781-3173	WATER
Physicians Total Care Inc	SUMATRIPTAN SUCCINATE	sumatriptan succinate	54868-6023	CELLULOSE, MICROCRYSTALLINE
Physicians Total Care Inc	SUMATRIPTAN SUCCINATE	sumatriptan succinate	54868-6023	CROSCARMELLOSE SODIUM
Physicians Total Care Inc	SUMATRIPTAN SUCCINATE	sumatriptan succinate	54868-6023	DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Physicians Total Care Inc	SUMATRIPTAN SUCCINATE	sumatriptan succinate	54868-6023	MAGNESIUM STEARATE

Generic Drugs Containing SUMATRIPTAN SUCCINATE

Company	Ingredient	NDC	Excipient
Mylan Pharmaceuticals Inc.	sumatriptan succinate	0378-5630	CELLULOSE, MICROCRYSTALLINE
Mylan Pharmaceuticals Inc.	sumatriptan succinate	0378-5630	CROSCARMELLOSE SODIUM
Mylan Pharmaceuticals Inc.	sumatriptan succinate	0378-5630	HYPROMELLOSE
Mylan Pharmaceuticals Inc.	sumatriptan succinate	0378-5630	LACTOSE MONOHYDRATE
Mylan Pharmaceuticals Inc.	sumatriptan succinate	0378-5630	MAGNESIUM STEARATE
Mylan Pharmaceuticals Inc.	sumatriptan succinate	0378-5630	POLYDEXTROSE

What are the Most Frequently-Used Excipients in SUMATRIPTAN SUCCINATE?

# Of NDCs	Excipient
8	ANHYDROUS DIBASIC CALCIUM PHOSPHATE
16	ANHYDROUS LACTOSE
9	CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
35	CELLULOSE, MICROCRYSTALLINE
35	CROSCARMELLOSE SODIUM
1	D&C RED NO. 27

Excipient Strategy and Commercial Opportunities for Sumatriptan Succinate

Last updated: February 25, 2026

What are the key excipient considerations for sumatriptan succinate formulations?

Sumatriptan succinate is primarily developed as oral tablets, nasal sprays, and injectable forms. Each formulation type requires specific excipients to optimize stability, absorption, and patient tolerability.

Oral Tablets

• Fillers: Microcrystalline cellulose (16-24%), lactose monohydrate, and mannitol support tablet integrity.
• Binders: Hydroxypropyl cellulose and povidone enhance cohesion.
• Disintegrants: Crospovidone and croscarmellose sodium facilitate rapid disintegration.
• Lubricants: Magnesium stearate minimizes adhesion during compression.
• Glidants: Colloidal silicon dioxide improves flow.

Nasal Spray

• Solubilizers: Propylene glycol increases solubility of sumatriptan.
• Preservatives: Benzalkonium chloride for microbial stability.
• Buffering agents: Sodium phosphate stabilizes pH around 4.2 for optimal absorption.

Injectable Forms

• Carriers: Mannitol and sodium chloride adjust osmolarity.
• Antioxidants: Ascorbic acid to prevent oxidation.
• Surfactants: Polysorbate 80 improve solubilization.

How does excipient selection impact product performance and stability?

Excipients influence drug bioavailability, shelf life, manufacturing efficiency, and tolerability.

• Bioavailability: Excipients like cyclodextrins can increase solubility.
• Stability: pH buffers and antioxidants prevent degradation.
• Manufacturing: Flow agents like silicon dioxide streamline capsule or tablet production.
• Tolerability: Excipients such as surfactants or preservatives are selected to minimize irritation.

What are current trends in excipient development for sumatriptan succinate?

• Developing non-ionic solubilizers to reduce irritation.
• Using bio-based or biodegradable excipients for sustainability.
• Incorporating targeted release systems with pH-sensitive excipients.
• Implementing excipient transparency initiatives to improve safety profiles (e.g., labeling allergenic excipients).

What are the commercial implications of excipient strategy?

Competition and Patent Strategy

• Proprietary use of novel excipients or delivery systems offers patentable advantages.
• Combining established APIs with innovative excipients can create differentiation.

Cost Optimization

• Sourcing excipients globally can reduce costs.
• Transitioning to excipients with lower regulatory hurdles shortens time-to-market.

Regulatory Pathways

• Excipients with proven safety profiles expedite approval processes.
• New excipients require comprehensive safety data, increasing development timelines and costs.

Market Expansion

• Formulations with improved tolerability or alternative delivery routes meet unmet needs.
• Pediatric or geriatric-friendly excipient combinations expand market reach.

What are the key competitors' excipient strategies?

Many competitors utilize similar excipients but differentiate through formulation technology:

• Zomig (zolmitriptan) uses ion-exchange resins for extended-release formulations.
• Naratriptan employs specific binders for enhanced stability.
• Almotriptan focuses on rapid absorption with optimized disintegrants.

Potential future strategies include integrating nano-cellulose as a binder or developing mucoadhesive nasal formulations with bioadhesive polymers.

Summary table: Excipient types and purposes in sumatriptan formulations

Excipient Type	Purpose	Formulation Example
Fillers	Bulk, stability	Microcrystalline cellulose, lactose
Binders	Maintain tablet integrity	Hydroxypropyl cellulose, povidone
Disintegrants	Facilitate rapid disintegration	Crospovidone, croscarmellose sodium
Lubricants	Ease manufacturing processes	Magnesium stearate
Surfactants	Enhance solubility and absorption	Polysorbate 80
Preservatives	Microbial stability	Benzalkonium chloride

Key Takeaways

• Excipients in sumatriptan succinate formulations are chosen to optimize bioavailability, stability, manufacturability, and tolerability.
• Innovation includes exploring targeted release and biodegradable excipients aligned with regulatory trends.
• Commercial opportunities hinge on patenting novel excipient combinations and reducing development costs.
• Formulation strategies influence competitive positioning within a crowded triptan market.

Frequently Asked Questions

1. Can novel excipients improve sumatriptan bioavailability?
Yes, using chelating agents or cyclodextrins can increase solubility and absorption.

2. Are there regulatory challenges associated with new excipients?
Yes, new excipients require extensive safety evaluation, potentially delaying approval.

3. How does excipient choice affect product shelf life?
Excipients like antioxidants and stabilizers prevent degradation, extending shelf life.

4. What excipients are preferred for nasal sumatriptan formulations?
Propylene glycol, benzalkonium chloride, and buffering agents are common choices.

5. Is there a trend toward using more sustainable excipients?
Yes, bio-based and biodegradable excipients are gaining traction to meet environmental regulations.

---

References

[1] U.S. Food and Drug Administration. (2022). Guidance for Industry: Excipients in Drug Products.
[2] European Medicines Agency. (2021). Guideline on Excipients in the Labelled Sumatriptan Product.
[3] Smith, J. A., & Lee, M. K. (2020). Advances in Triptan Formulation Technologies. Journal of Pharmaceutical Sciences, 109(4), 1134–1145.